Arcturus Therapeutics Holdings (ARCT) Non-Current Debt (2018 - 2025)

Arcturus Therapeutics Holdings' Non-Current Debt history runs 7 years deep, the most recent figure standing at $15.0 million for Q1 2025.

• Quarterly Non-Current Debt changed N/A year-over-year to $15.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $15.0 million (changed N/A YoY) and the FY2022 annual result came in at $50.4 million, up 24.04% from the prior year.
• Non-Current Debt was $15.0 million for Q1 2025 at Arcturus Therapeutics Holdings, down from $20.0 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $58.1 million in Q1 2021 and bottomed at $15.0 million in Q1 2025.
• A 4-year average of $39.0 million and a median of $39.9 million in 2021 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2021 — Non-Current Debt soared 286.92% — and 2023, when it tumbled 37.57%.
• Arcturus Therapeutics Holdings' Non-Current Debt stood at $40.6 million in 2021, then gained by 24.04% to $50.4 million in 2022, then sank by 60.32% to $20.0 million in 2023, then slipped by 25.0% to $15.0 million in 2025.
• Business Quant data shows ARCT's Non-Current Debt at $15.0 million in Q1 2025, $20.0 million in Q3 2023, and $50.4 million in Q4 2022.